|
시장보고서
상품코드
2055229
암 줄기세포 시장 : 암 유형별, 제품 유형별, 줄기세포 유래별, 작용기전별, 용도별, 최종사용자별, 지역별Cancer Stem Cells Market, By Cancer Type, By Product Type, By Stem Cell Source, By Mode of Action, By Application, By End User, By Geography |
||||||
암 줄기세포 시장은 2026년 36억 7,000만 달러로 추정되고, 2033년에 71억 1,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 9.9%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 36억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.90% | 2033년 시장 규모 예측 : | 71억 1,000만 달러 |
암 줄기세포(CSCs)는 종양 내에 존재하는 고유한 세포 하위 집단으로, 자가 재생 능력과 다계통 분화 능력을 갖추고 있어 종양학 연구 개발에서 중요한 연구 대상으로 주목받고 있습니다. 이러한 세포들은 종양 형성의 시작, 전이 촉진, 치료 저항성의 원인이 되는 능력을 특징으로 하며, 정밀 암 치료의 최전선에 위치하고 있습니다.
세계 암 줄기세포 시장은 이러한 포착하기 어려운 세포 집단을 식별, 분리 및 표적화하기 위해 설계된 연구 도구, 치료법 및 진단 솔루션으로 구성된 종합적인 생태계를 아우르고 있습니다. 이 시장은 유방암, 폐암, 대장암, 뇌암, 혈액암 등 다양한 유형의 암에 걸쳐 있으며, 그 응용 범위는 신약 개발, 바이오마커 확인, 맞춤형 치료 전략에 이르기까지 다양합니다. CSC에 대한 생물학적 이해가 깊어짐에 따라, 유세포 분석 시스템, 세포 배양 배지, 항체, 저분자 억제제 등의 전문 기술에 대한 대규모 투자가 촉진되고 있습니다.
시장 역학
세계 암 줄기세포 시장은 그 성장과 기술 발전을 전반적으로 가속화하는 몇 가지 주요 촉진요인에 힘입어 성장하고 있습니다. 주요 성장 동력은 전 세계적으로 기하급수적으로 증가하고 있는 암의 부담에 있습니다. 매년 1,900만 건 이상의 신규 사례가 진단되고 있으며, 치료 저항성이나 종양 재발에 대처할 수 있는 혁신적인 치료 접근법에 대한 시급한 필요성이 대두되고 있습니다.
정부 기관, 제약 회사, 생명공학 기업의 암 연구에 대한 막대한 투자로 인해 CSC 관련 연구 자금 조달이 크게 확대되었습니다. 한편, 줄기세포 생물학과 암 발병 기전에 관한 획기적인 발견은 신약 개발과 맞춤형 의료 접근법에 새로운 길을 열었습니다. 단일 세포 시퀀싱, CRISPR 유전자 편집, 첨단 세포 선별 시스템과 같은 첨단 기술 플랫폼은 CSC 연구 역량에 혁명을 일으켜, 이러한 세포 집단의 보다 정확한 동정 및 특성 평가를 가능하게 했습니다.
그러나 시장 성장에는 전문적인 연구 장비나 시약에 따른 높은 비용 등 뚜렷한 제약 요인이 존재합니다. 이로 인해 소규모 연구 기관이나 개발도상 지역의 접근이 제한될 수 있습니다. 또한, CSC의 희소성과 표현형의 가소성으로 인한 분리 및 특성 분석상의 기술적 과제는 연구자들에게 큰 장벽이 되고 있습니다. 게다가 CSC를 표적으로 하는 치료법에 대한 엄격한 규제 요건은 개발 기간을 길게 만들고 비용을 증가시키고 있습니다.
이러한 과제가 있음에도 불구하고, 암의 조기 발견 및 모니터링에 활용되는 액체 생검 기술의 새로운 응용 분야 개발, CSC가 중요한 역할을 하는 희귀 암종에 대한 연구 확대, 생체 내 종양 환경을 보다 충실하게 재현하는 3D 세포 배양 및 오가노이드 기술의 보급 확대를 통해 이 시장에는 큰 기회가 존재합니다. 종양 세포 전체와 암 줄기세포 집단을 모두 표적으로 삼는 병용 요법에 대한 관심이 높아지고 있는 데다, 바이오마커 발굴 프로그램에 대한 투자가 증가하고 있어, 향후 몇 년간 이 시장은 지속적인 성장과 혁신을 이룰 것으로 전망됩니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 암 줄기세포 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 세계 암 줄기세포 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 세계 암 줄기세포 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 암 줄기세포 시장 : 암 유형별, 2021-2033년
제5장 세계의 암 줄기세포 시장 : 제품 유형별, 2021-2033년
제6장 세계의 암 줄기세포 시장 : 줄기세포 유래별, 2021-2033년
제7장 세계의 암 줄기세포 시장 : 작용기전별, 2021-2033년
제8장 세계의 암 줄기세포 시장 : 용도별, 2021-2033년
제9장 세계의 암 줄기세포 시장 : 최종사용자별, 2021-2033년
제10장 세계의 암 줄기세포 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌과 조사 방법
LSHCancer Stem Cells Market is estimated to be valued at USD 3.67 Bn in 2026 and is expected to reach USD 7.11 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.67 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.90% | 2033 Value Projection: | USD 7.11 Bn |
Cancer stem cells (CSCs) represent a unique subpopulation of cells within tumors that possess self-renewal capabilities and multilineage differentiation potential, making them critical targets in oncology research and therapeutic development. These cells are characterized by their ability to initiate tumor formation, drive metastasis, and contribute to treatment resistance, positioning them at the forefront of precision cancer medicine.
The global cancer stem cells market encompasses a comprehensive ecosystem of research tools, therapeutic agents, and diagnostic solutions designed to identify, isolate, and target these elusive cellular populations. This market spans various cancer types including breast, lung, colorectal, brain, and hematological malignancies, with applications extending across drug discovery, biomarker identification, and personalized treatment strategies. The increasing understanding of CSC biology has catalyzed significant investments in specialized technologies such as flow cytometry systems, cell culture media, antibodies, and small molecule inhibitors.
Market Dynamics
The global cancer stem cells market is propelled by several key drivers that collectively accelerate its expansion and technological advancement. The primary growth catalyst stems from the exponentially increasing global cancer burden, with over 19 million new cases diagnosed annually, creating urgent demand for innovative therapeutic approaches that address treatment resistance and tumor recurrence.
Substantial investments in cancer research by government agencies, pharmaceutical companies, and biotechnology firms have significantly enhanced funding availability for CSC-related studies, while breakthrough discoveries in stem cell biology and cancer pathogenesis have opened new avenues for drug development and personalized medicine approaches. Advanced technological platforms including single-cell sequencing, CRISPR gene editing, and sophisticated cell sorting systems have revolutionized CSC research capabilities, enabling more precise identification and characterization of these cellular populations.
However, market growth faces notable restraints including the high costs associated with specialized research equipment and reagents, which can limit accessibility for smaller research institutions and developing regions. Technical challenges in CSC isolation and characterization due to their rarity and phenotypic plasticity create significant barriers for researchers, while stringent regulatory requirements for CSC-targeting therapeutics extend development timelines and increase costs.
Despite these challenges, the market presents substantial opportunities through emerging applications in liquid biopsy development for early cancer detection and monitoring, expanding research into rare cancer types where CSCs play critical roles, and growing adoption of 3D cell culture and organoid technologies that better recapitulate in vivo tumor environments. The increasing focus on combination therapies targeting both bulk tumor cells and cancer stem cell populations, coupled with rising investments in biomarker discovery programs, positions the market for sustained growth and innovation in the coming years.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cancer stem cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Lineage Cell Therapeutics, Inc., FUJIFILM Irvine Scientific, Thermo Fisher Scientific Inc., Merck KGaA, MacroGenics, Inc., Miltenyi Biotec, AbbVie Inc., STEMCELL Technologies Inc., Bionomics, Sino Biological Inc., Celgene Corporation, Incyte Corporation, Novartis AG, Pfizer Inc., and Lonza Group AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cancer stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer stem cells market
Market Segmentation
- Cancer Type Insights (Revenue, USD Bn, 2021 - 2033)
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Brain Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Bladder Cancer
- Liver Cancer
- Other Cancer Types
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Cell"'culturing products
- Cell"'separation products
- Cell analysis products
- Molecular analysis products
- Other supporting tools/reagents (e.g. media, markers, assay kits)
- Stem-cell Source Insights (Revenue, USD Bn, 2021 - 2033)
- Bone Marrow-derived
- Peripheral Blood-derived
- Umbilical Cord Blood-derived
- Induced Pluripotent Stem Cells (iPSCs)
- Mode of Action Insights (Revenue, USD Bn, 2021 - 2033)
- Targeted Cancer Stem Cell Therapies
- Immunotherapy-based Approaches
- Others (Chemotherapy Resistance Reversal Agents)
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Research and Development
- Biomarker Identification
- Drug Discovery and Screening
- Tumorigenesis Studies
- Diagnostic Applications
- Cancer Prognosis
- Minimal Residual Disease Detection
- Therapeutic Applications
- Clinical Treatment
- Adjunct Therapy
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and cancer treatment centers
- Pharmaceutical and biotechnology companies
- Academic and research institutes/laboratories
- Contract research organizations (CROs)
- Other end"'users (Cell"'banks, diagnostic centers)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Lineage Cell Therapeutics, Inc.
- FUJIFILM Irvine Scientific
- Thermo Fisher Scientific Inc.
- Merck KGaA
- MacroGenics, Inc.
- Miltenyi Biotec
- AbbVie Inc.
- STEMCELL Technologies Inc.
- Bionomics
- Sino Biological Inc.
- Celgene Corporation
- Incyte Corporation
- Novartis AG
- Pfizer Inc.
- Lonza Group AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cancer Stem Cells Market, By Cancer Type
- Global Cancer Stem Cells Market, By Product Type
- Global Cancer Stem Cells Market, By Stem"'Cell Source
- Global Cancer Stem Cells Market, By Mode of Action
- Global Cancer Stem Cells Market, By Application
- Global Cancer Stem Cells Market, By End User
- Global Cancer Stem Cells Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Cancer Stem Cells Market, By Cancer Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Brain Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pancreatic Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Cancer Types
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Cancer Stem Cells Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cell"'culturing products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cell"'separation products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cell analysis products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Molecular analysis products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other supporting tools/reagents (e.g. media, markers, assay kits)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Cancer Stem Cells Market, By Stem"'Cell Source, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bone Marrow-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Peripheral Blood-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Umbilical Cord Blood-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Induced Pluripotent Stem Cells (iPSCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Cancer Stem Cells Market, By Mode of Action, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Targeted Cancer Stem Cell Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunotherapy-based Approaches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Chemotherapy Resistance Reversal Agents)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Cancer Stem Cells Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biomarker Identification
- Drug Discovery and Screening
- Tumorigenesis Studies
- Diagnostic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cancer Prognosis
- Minimal Residual Disease Detection
- Therapeutic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinical Treatment
- Adjunct Therapy
9. Global Cancer Stem Cells Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and cancer treatment centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pharmaceutical and biotechnology companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Academic and research institutes/laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Contract research organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other end users (Cell"'banks, diagnostic centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Cancer Stem Cells Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Stem"'Cell Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Stem"'Cell Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Stem"'Cell Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Stem"'Cell Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Stem"'Cell Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cancer Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Stem"'Cell Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Lineage Cell Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FUJIFILM Irvine Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MacroGenics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STEMCELL Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bionomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sino Biological Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Incyte Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
